BRKR earnings date and last-quarter result: last quarter miss, P/E -249.96. Updated 2026-07-23.
Bruker (BRKR) Research Hub
Bruker (BRKR) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 58.23 USD (+1.11%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -249.96, market cap 9.19B. This hub links to the full technical, earnings and options research available for BRKR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 58.23 USD (+1.11%) |
| 52-week range | 50.12 USD – 66.98 USD |
| Trend regime | Range |
| 14-day RSI | 43.1 (Bearish) |
| Trailing P/E | -249.96 |
| Market cap | 9.19B |
| Dividend yield | 0.33% |
Available research for BRKR
Covered Call on BRKR: how it works, illustrative setup around the real 58.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BRKR: how it works, illustrative setup around the real 58.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BRKR: how it works, illustrative setup around the real 58.23 USD price, max profit/loss, breakeven and when to use it. Educational.
BRKR technical analysis: range, last 58.23 USD, RSI 43.1, 52w range 50.12 USD–66.98 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BRKR in?
Bruker (BRKR) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is BRKR in an uptrend or downtrend?
As of 2026-10-26, BRKR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BRKR's trailing P/E ratio?
BRKR's trailing P/E is -249.96, with a market cap of 9.19B. See the earnings research page for full valuation detail.